Kim Cantin

A double-blind, placebo-controlled, randomized trial of XP-828L (800 mg) on the quality of life and clinical symptoms of patients with mild-to-moderate psoriasis.

R. Drouin, O. Moroni, Kim Cantin, 2008, Alternative medicine review : a journal of clinical therapeutic.

XP-828L (Dermylex), a new whey protein extract with potential benefit for mild to moderate psoriasis.

P. Poubelle, S. Gauthier, Y. Pouliot, 2007, Canadian journal of physiology and pharmacology.

XP-828 L ( Dermylex ) , a new whey protein extract with potential benefit for mild to moderate psoriasis 1

P. Poubelle, S. Gauthier, Y. Pouliot, 2007 .

XP-828 L in the Treatment of Mild-to-Moderate Psoriasis : A Randomized , Double-blind , Placebo-controlled Study

R. Bissonnette, Y. Poulin, P. Poubelle, 2007 .

XP-828L in the Treatment of Mild to Moderate Psoriasis: Randomized, Double-Blind, Placebo-Controlled Study

R. Bissonnette, Y. Poulin, P. Poubelle, 2006, Journal of cutaneous medicine and surgery.